A notable advancement in diabetes management is emerging with the introduction of tirzepatide at a dosage of 45mg. This innovative version builds upon the existing success of tirzepatide, a dual GIP and GLP-1 agonist, https://flynnrtcz388209.eveowiki.com/2324251/significant_introduction_tirzepatide_dose_for_diabetes_management